Aardvark Therapeutics AARD
NASDAQ AARD
$1.38 +0.02 (+1.85%)
As of: Nov 10, 2026 · 2:20 PM EST

Aardvark Therapeutics (AARD) Assets (2024 - 2026)

Updated

Aardvark Therapeutics' Assets came in at $81.46 million for Q2 2026, down 44.8% from $147.48 million a year earlier and down 17.4% from the prior quarter.

Analysis

Aardvark Therapeutics (AARD) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Aardvark Therapeutics' Assets was $117.18 million, up 51.2% from FY2024.

  • Going back by year, Assets was $77.51 million in FY2024.
  • The Q2 2026 figure represents the lowest quarterly Assets since Q4 2024.
  • Business Quant data shows AARD's Assets at $98.59 million (Q1 2026), $117.18 million (Q4 2025) and $133.23 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 197.43 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 147.68 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 115.83 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 205.00 Bn
10 Aardvark Therapeutics 30.58 Mn -43.32 Mn - 81.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 81.46 Mn
Mar 31, 2026 98.59 Mn
Dec 31, 2025 117.18 Mn
Sep 30, 2025 133.23 Mn
Jun 30, 2025 147.48 Mn
Mar 31, 2025 157.03 Mn
Dec 31, 2024 77.51 Mn
API Access

Aardvark Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=AARD&period=max&api_key=YOUR_API_KEY